Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol

Hassan TONEKABONI, Seyed and GHAZAVI, Ahad and FAYYAZI, Afshin and KHAJEH, Ali and Mahdi TAGHDIRI, Mohammad and ABDOLLAH GORJI, Fatemeh and AZARGHASHB, Eznollah (2013) Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol. Iranian Journal of Child Neurology, 7 (1). pp. 9-14.

[thumbnail of 4071-Article Text (Word file)-13008-2-10-20130626 (1).pdf] Text
4071-Article Text (Word file)-13008-2-10-20130626 (1).pdf - Published Version

Download (265kB)

Abstract

How to Cite this Article: Tonekaboni SH, Ghazavi A, Fayyazi A, Khajeh A, Taghdiri MM, Abdollah Gorji F, Azargashb E. Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol. Iran J Child Neurol. 2013 Winter; 7 (1):9-14.

Objective

Headache is a common disabling neurological disorder and migraine comprises more than half the causes of recurrent headaches in children. Despite extended prevalence of this type of headache there is lack of evidence about best drug treatment for migraine. So we aimed to compare the therapeutic effects of these drugs on childhood migraine.

Materials & Methods

In the current study, a randomized clinical trial consisting of 78 patients according to 2004 International Headache Association criteria were randomly assigned to two groups that matched by age and sex. One of these two groups was treated with Topiramate, while the other was given Propranolol. After one and four months, the efficiency of these treatments was measured in terms of frequency, severity and duration of migraine attacks.

Results

Results obtained from the data collected showed that of these 78 studied patients, 38 patients received Topiramate treatment (group A) and the rest (40 patients; group B) was treated with Propranolol. The average age of group A was 8.5± 2.9 years and that of group B was 8.3 ± 2.8 years. No significant difference was observed between these two groups in terms of reduction in frequency, severity and duration of migraine attacks.

Conclusion

Results showed that both treatments had the same efficiency in healing migraine headaches and there was no significant difference between their treating results. However, further studies are needed to examine medical effects of these two medicines.

Item Type: Article
Subjects: ScienceOpen Library > Medical Science
Depositing User: Managing Editor
Date Deposited: 17 Feb 2023 08:20
Last Modified: 28 May 2024 05:26
URI: http://scholar.researcherseuropeans.com/id/eprint/520

Actions (login required)

View Item
View Item